top of page
Medical Consultation

Clinical Research

We offer hope to those with retinal diseases by providing access to clinical trials that could potentially improve their condition and advance the treatment outcomes for future patients

(925) 265-4146

Current Clinical Trials

Central Vein Retinal Occlusion (CRVO)
Diabetic Macular Edema (DME)
Geographic Atrophy (GA)
Intermediate Age-Related Macular Degeneration (iAMD)
Macular Telangiectasia (MacTel)
Wet Age-Related Macular Degeneration (wAMD)

Central Vein Retinal Occlusion (CRVO)

RIVOLI

Roche

A phase IB, Multicenter, Randomized, Double Masked, Active Comparator-Controlled Study to investigate the biological activity, safety, tolerability, pharmacokinetics and pharmacodynamics of ro7200394 in participants with macular edema secondary to central retinal vein occlusion

Diabetic Macular Edema (DME)

ASPIRE

Unity Biotechnology

A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With Diabetic Macular Edema

STAMP

Allergan

Steroid vs. Anti-VEGF for Diabetic Macular Edema Prior to Phacoemulsification

PREGONDA

Roche

A Multi-Center, Non-Randomized, Open-Label, Multiple Ascending Dose, Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7497372 Following Intravitreal Administration in Participation with Diabetic Macular Edema

Geographic Atrophy (GA)

MAGNIFY

Cognition Therapeutics

A Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Phase 2 Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants with Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

ISIGHT

I-Lumen

Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT): A Multicenter, Randomized, Sham-controlled, Feasibility Device Trial.

GARLAND

Apellis Pharmaceuticals, Inc

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World
Safety, Tolerability and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients with
Geographic Atrophy Secondary to Age-Related Macular Degeneration

PARASOL

Janssen

A Phase 2b, Randomized, Double-masked, Multicenter, Dose-ranging, Sham-controlled Clinical Trial to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Intermediate Age-Related Macular Degeneration (iAMD)

HONU

Genentech

A Multicenter, Prospective, Observational Study of the Progression of Intermediate Age-Related Macular Degeneration

Macular Telangiectasia (MacTel)

Wet Age-Related Macular Degeneration (wAMD)

NHOR

The Lowy Medical Research Institute

The Natural History Observation Registry (NHOR) is a world-wide registry of individuals with Macular Telangiectasia type 2, and their family members.

CRVO
DME
GA
iAMD
MacTel
wAMD

ASCENT

AbbVie

A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD

PROTOCOL AO

DRCR

This study compares Home OCT-Guided Treatment versus Treat and Extend for the management of neovascular (wet) AMD.

CONQUER

Affamed Therapeutics

A Prospective, Multi-Center, Open-label, Sequential, Multiple Ascending-Dose and High Concentration Cohorts Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AM712 Following Intravitreal Administration in Patients With Neovascular Age-related Macular Degeneration.

Closed Trials

AERIE

ALTISSIMO

AVENUE

BI GA

ALEXION

ARCHWAY

BARDENAS

BOULEVARD

ALLUVIUM

AVANTE

BHAM

DERBY

DRCR

GALLEGO

OMASPECT

RHINE

FOCUS

KINGFISHER

PANDA

SAPPHIRE

GALE

NTMT

RAVEN

SPECTRI

STAIRWAY

STAMP

VAPOR

SUSHI

bottom of page